Healthcare provider profile · identity verified

Ricardo S. Lim, MD

Internal Medicine · RIVERSIDE, CA · NPI 1336216159

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1025	381
Amlodipine Besylate	Amlodipine Besylate	585	220
Lisinopril	Lisinopril	452	165
Losartan Potassium	Losartan Potassium	316	127
Metformin Hcl	Metformin Hcl	251	103
Levothyroxine Sodium	Levothyroxine Sodium	248	94
Terazosin Hcl	Terazosin Hcl	239	87
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	208	66
Humulin N	Insulin Nph Human Isophane	185	50
Pradaxa	Dabigatran Etexilate Mesylate	170	38
Atenolol	Atenolol	167	58
Rosuvastatin Calcium	Rosuvastatin Calcium	156	63
Metoprolol Tartrate	Metoprolol Tartrate	152	50
Hydralazine Hcl	Hydralazine Hcl	151	50
Metformin Hcl Er	Metformin Hcl	139	61
Hydrochlorothiazide	Hydrochlorothiazide	133	54
Omeprazole	Omeprazole	132	59
Meloxicam	Meloxicam	126	40
Simvastatin	Simvastatin	121	41
Furosemide	Furosemide	105	45
Potassium Chloride	Potassium Chloride	95	48
Tamsulosin Hcl	Tamsulosin Hcl	94	42
Nabumetone	Nabumetone	91	47
Alendronate Sodium	Alendronate Sodium	90	37
Glipizide	Glipizide	90	38
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	82	26
Pantoprazole Sodium	Pantoprazole Sodium	80	36
Allopurinol	Allopurinol	78	30
Humulin N Kwikpen	Insulin Nph Human Isophane	76	25
Albuterol Sulfate Hfa	Albuterol Sulfate	68	44
Finasteride	Finasteride	66	25
Pravastatin Sodium	Pravastatin Sodium	66	24
Clopidogrel	Clopidogrel Bisulfate	65	26
Gabapentin	Gabapentin	64	34
Carvedilol	Carvedilol	63	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	62	36
Humulin R	Insulin Regular, Human	61	24
Trazodone Hcl	Trazodone Hcl	59	22
Spiriva Respimat	Tiotropium Bromide	58	15
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	56	20
Glipizide Er	Glipizide	55	24
Veo Insulin Syringe	Syrge-Ndl,ins 0.3 Ml Half Mark	53	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	19
Breyna	Budesonide/Formoterol Fumarate	48	27
Bisoprolol Fumarate	Bisoprolol Fumarate	46	19
Ozempic	Semaglutide	45	14
Ibuprofen	Ibuprofen	44	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	43	11
Wixela Inhub	Fluticasone Propion/Salmeterol	40	11
Acyclovir	Acyclovir	39	11
Jardiance	Empagliflozin	39	17
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	39	13
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	37	37
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	12
Alvesco	Ciclesonide	31	15
Benazepril Hcl	Benazepril Hcl	31	suppressed
Cephalexin	Cephalexin	30	27
Famotidine	Famotidine	30	12
Colchicine	Colchicine	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	28	suppressed
Ezetimibe	Ezetimibe	26	12
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	26	13
Lovastatin	Lovastatin	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	11
Duloxetine Hcl	Duloxetine Hcl	24	14
Triamcinolone Acetonide	Triamcinolone Acetonide	24	17
Metoprolol Succinate	Metoprolol Succinate	23	11
Montelukast Sodium	Montelukast Sodium	23	11
Nitroglycerin	Nitroglycerin	22	12
Ondansetron Odt	Ondansetron	22	12
Spironolactone	Spironolactone	22	suppressed
Tramadol Hcl	Tramadol Hcl	21	15
Sertraline Hcl	Sertraline Hcl	19	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	18	18
Eliquis	Apixaban	16	suppressed
Hydrocortisone	Hydrocortisone	16	11
Escitalopram Oxalate	Escitalopram Oxalate	14	suppressed
Lactulose	Lactulose	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Digoxin	Digoxin	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	12	12
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error